IGC PHARMA, INC. Repayments of Long-Term Debt
IGC PHARMA, INC. (IGC) reported Repayments of Long-Term Debt of $3.00 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-03-18
- IGC PHARMA, INC. repayments of long-term debt for the quarter ending 2025-12-31 was $1.00K, a 0.00% change year-over-year.
- IGC PHARMA, INC. repayments of long-term debt for the quarter ending 2025-03-31 was $0.00.
- IGC PHARMA, INC. repayments of long-term debt for the quarter ending 2024-12-31 was $1.00K.
- IGC PHARMA, INC. repayments of long-term debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- IGC PHARMA, INC. repayments of long-term debt for fiscal 2025 was $3.00K.
- IGC PHARMA, INC. repayments of long-term debt for fiscal 2012 was $0.00.
- IGC PHARMA, INC. repayments of long-term debt for fiscal 2011 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 3 month as first filed | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $1.00K derived: 10-KT 9 month − 10-Q 6 month · filed 2026-03-18 | $3.00K 10-KT · filed 2026-03-18 | |||
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-14 | ||||
| 2025-03-31 | $0.00 derived: 10-KT 12 month − 10-KT 9 month · filed 2026-03-18 | $1.00K derived: sum of 2 quarters · filed 2026-03-18 | $3.00K 10-KT · filed 2026-03-18 | ||
| 2024-12-31 | $1.00K derived: 10-KT 9 month − 10-Q 6 month · filed 2026-03-18 | $3.00K 10-KT · filed 2026-03-18 | |||
| 2024-09-30 | $2.00K 10-Q · filed 2025-11-14 | ||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 | ||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | ||||
| 2018-12-31 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $1.68M derived: sum of 2 quarters · filed 2020-02-10 | $1.88M 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $202.00K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $201.00K 10-Q · filed 2019-08-09 | $201.13K 10-Q · filed 2018-08-03 | |||
| 2017-12-31 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | -$172.84K derived: sum of 2 quarters · filed 2019-02-12 | $107.00K 10-Q · filed 2019-02-12 | ||
| 2017-09-30 | -$185.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $94.00K 10-Q · filed 2018-10-16 | |||
| 2017-06-30 | $279.84K 10-Q · filed 2018-08-03 | ||||
| 2012-03-31 | $0.00 10-K · filed 2012-07-16 | ||||
| 2011-03-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-16 | $0.00 10-K · filed 2012-07-16 | |||
| 2010-12-31 | $200.00K 10-Q · filed 2012-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |